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B I O C H E M I S T R Y
Lysis of membrane lipids promoted by small organic 
molecules: Reactivity depends on structure but  
not lipophilicity
Hannah M. Britt, Aruna S. Prakash*†, Sanna Appleby‡, Jackie A. Mosely, John M. Sanderson§
Several organic molecules of low molecular weight (<150 Da) are demonstrated to have substantial membrane-lytic 
potential despite having a low predicted lipophilicity (logD < 1 at neutral pH). In aqueous liposome dispersions, 
38 aromatic compounds were tested for their ability to either promote lipid hydrolysis or directly participate in 
chemical reactions with lipid molecules. Behaviors observed included acyl transfer from the lipid to form a lipidated 
compound, both with and without concomitant lysolipid formation; increases in the rate of lipid hydrolysis with-
out lipidation; and no reactivity. The variation in activity, including a notably higher activity for heterocycles such 
as amino-substituted benzimidazoles and indazoles, demonstrates the potential to predict or “design-in” lytic 
activity once the rules that govern reactivity are better understood. The nature of this chemical instability has 
significant ramifications for the use or presence of lipids in diverse fields such as materials chemistry, food chemistry, 
and cell physiology.
INTRODUCTION
Direct chemical reactivity between lipids and the molecules that 
partition into membranes is very rarely considered. The chemical 
reactivity that is well described extends only to hydrolysis reactions 
involving bulk solvent (1–3) and autoxidation reactions (4–6), nei-
ther of which directly includes molecules that associate with mem-
branes as part of their normal activity. In the eyes of many, lipid 
membranes, then, represent a stable environment into which mole-
cules bind or insert as part of their normal function. In the classic 
work on the fluid-mosaic model, for example, it is stated that “…the 
phospholipids and proteins of membranes do not interact strongly; 
in fact, they appear to be largely independent” (7).
However, this notion of chemical stability has begun to be chal-
lenged. The transfer of a fatty acyl group from a membrane lipid to 
a membrane-embedded species (Fig. 1) has been described for 
peptides (aminolysis and transesterification) (8–11), and it has been 
suggested that similar reactions may be significant for some mem-
brane proteins (12). Recently, similar acyl transfer reactivity was 
described for the drug propranolol, both in vitro and in vivo, to 
form a lipidated drug molecule (13). The reactivity of propranolol is of 
particular significance as it extends the observation of acyl transfer 
to low–molecular weight species, suggesting that membranes may 
be far more reactive than previously thought. It is currently still not 
clear how general this reactivity is, however, as other molecules, in-
cluding fluoxetine, sertraline, chloroquine (13), haloperidol, spiperone 
(14), and raclopride (15), have been shown to promote the forma-
tion of lysolipids in model systems by hydrolysis (Fig. 1) without 
undergoing concurrent lipidation. Acyl transfer and hydrolysis may 
indeed be competing reactions, and the chemical landscape is fur-
ther complicated by the potential for lipidated products to also cat-
alyze lytic reactions of lipids, as well as the lysolipid products 
themselves, to be acyl donors in transfer reactions (while noting, in 
addition, that Fig. 1 shows a reaction of the acyl group from one site 
in the lipid when transfer of either is feasible). All the molecules 
described above that undergo lipidation reactions or influence the 
rate of lipid hydrolysis have a significant affinity for lipid membranes, 
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Fig. 1. Lytic reactions of lipids in the presence of membrane-associated mole-
cules. Reactions include acyl transfer from the lipid to the bound molecule and 
lipid hydrolysis catalyzed by the bound molecule. Both processes form lysolipids as 
coproducts. Note that, for clarity, only initial transfer of the sn-2 acyl group from 
the lipid is depicted, although the initial transfer of either acyl group is possible.
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and it is therefore not clear whether the reactivity will extend to 
lower–molecular weight species with much lower membrane affin-
ity. Demonstration of such activity would not only change funda-
mental thinking on lipid membrane stability but also have additional 
implications for our understanding of membrane biology as there is 
some indication that lytic activity is responsible for downstream ef-
fects in vivo (13). Both the fatty acids and the lysolipids formed by 
these processes have substantial effects on membrane properties at 
abundance levels as low as 1 mol % due to their noncylindrical 
shape (16). Consequences of the presence of lipid lysis products in-
clude, for example, a notable increase in the permeability of the 
membrane and the ability to trigger lipid biosynthetic pathways (17).
It is of fundamental interest to examine the extent to which or-
ganic molecules that partition reversibly into membranes are involved 
in lytic reactions. To that end, we examined a panel of compounds 
(Fig. 2) that include a range of aromatic and heteroaromatic ring 
systems combined with the presence of at least one nucleophilic 
center, covering a range (table S1) of predicted values for logP 
(−1.19 to 3.75), logD (−2.04 to 2.34), and pKa (where Ka is the acid 
dissociation constant) (2.98 to 12.48) (18) for the nucleophilic center, 
as well as varying separation of the nucleophilic center from the 
ring. Our objectives were to establish that (i) low–molecular weight 
molecules with low predicted logP/logD can partake in membrane- 
lytic reactions (i.e., strong membrane interaction is not a require-
ment for lytic activity); (ii) reactivity exhibits selectivity according 
to molecular structure and, in principle, therefore can be predicted 
or designed; and (iii) the formation of lysolipids can be used as an 
overall measure of the lytic potential of a given compound.
RESULTS
Each of the compounds in Fig. 2 was incubated under identical 
conditions with liposomes composed of 1,2-dioleoyl-sn-glycero- 
3- phosphocholine (DOPC) or a 4:1 mixture of DOPC with 
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Fig. 2. Compounds investigated in this study. 
Table 1. Summary of compound reactivities with lipid membranes 
composed of DOPC or DOPC/DOPS (4:1). All experiments were 
conducted at 37°C, pH 7.4, [lipid] = 1.27 mM, [compound] = 127 M, and 
were analyzed after 24 hours unless otherwise indicated. Lysolipid 
concentration data are provided in table S2. OPC concentration changes 
are determined with reference to a control without compound, allowing 
for an experimental error of 20% (determined from replicate 
measurements). “Clear” lipidation signifies that lipidated compounds were 
clearly visible in the LC-MS analysis after 24 hours, with corroborating 
data available. Corroborating data include MS/MS fragmentation, 
comparison with authentic samples, or expected relative retention times 
for oleoyl and palmitoyl species in experiments with 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC). Compounds underlined gave notably 
strong ion intensities (>104) for the lipidated derivative. “Potential” lipidation 
signifies that a peak with correct mass/charge ratio (m/z) was detected in 
LC-MS analysis, sometimes after 3 days, but without corroborating data. 
Lipid [OPC] change
Lipidation
Clear Potential No evidence
DOPC
Increase 10h, 11b, 21* 8, 10j, 12 11c†, 15*, 22*†
None 10i, 17 3, 10d, 18*, 20
1, 2, 4–7, 10b, 
10c, 10e-g, 
11a, 11d, 13, 
16, 19
Decrease 9a, 9b, 9c, 9d, 9e, 10a, 14 – –
DOPC + 
DOPS (4:1)
Increase 9e, 10a, 10i, 11b 3, 8, 10j
11a, 11c†, 
11d, 13, 16
None 9a, 9b, 9c, 9d, 10h, 14, 17
10d, 12, 
18*, 19
1, 2, 4–7, 10b, 
10c, 10e-g, 15*
Decrease 21* 20 22*
*Samples analyzed after 72 hours.   †Notably high [OPC].
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1,2-dioleoyl-sn-glycero-3-phosphoserine (DOPS) and the concen-
tration of the lysolipids 1-oleoyl-sn-glycero-3-phosphocholine 
(1-OPC) and 2-oleoyl-sn-glycero-3-phosphocholine (2-OPC) assayed 
by liquid chromatography–mass spectrometry (LC-MS) after peri-
ods of 24 and 72 hours. At the same time, analyses were conducted 
to directly detect the lipidated compound. Because of the unfeasibility 
of obtaining lipidated calibration standards for every compound 
tested, the results were interpreted qualitatively and are summarized 
in Table 1 and table S2.
Initial screens for reactivity
From Table 1, it is immediately clear that the full range of com-
pound reactivity with lipids is exhibited, with some molecules, such 
as 9a-e, providing clear evidence of considerable reactivity and others, 
such as 10e-g, giving no discernable change. Of the 38 compounds 
tested, 12 were found to undergo unambiguous lipidation, with 9 of 
these producing high ion intensities for the lipidated compound. Of 
these nine, five belong to one class of compound (indazole, 9a-e) 
and three to a related class of compound (benzimidazole, 10a, 10h, 
and 10i). It is clear therefore that lipidation activity has a structural 
dependence.
Compound 9e (Figs. 3 and 4) demonstrates the complex rela-
tionship between lipidation and lysolipid formation exhibited by 
many of the compounds for which there is clear lipidation. In the 
initial periods following the addition of 9e to neutral liposomes 
[DOPC and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC)], the concentration of lysolipid reduces in comparison to a 
control sample without 9e. Two potential reasons for this decrease 
are that either 9e binding modifies membrane properties in such a 
manner that the rate of lipid hydrolysis is reduced, or 9e is more 
reactive toward lysolipids than lipids. After longer time periods in 
the presence of 9e, the extent of lysolipid formation eventually sur-
passes lysolipid generation in the control sample.
Relationship between lysolipid formation and lipidation
Across the range of compounds that undergo demonstrable lipida-
tion in DOPC, all possible types of simultaneous lysolipid change 
relative to control samples are seen, from significant increases for 
10h and 21 to an almost complete absence of lysolipid for com-
pound 9b. Decreases in lysolipid concentration in DOPC mem-
branes are restricted to compounds that undergo lipidation. For 
compounds that yield no discernable lipidation products, there is 
either no change in lysolipid levels or an increase. Overall, the data 
are sufficient to indicate that there is no clear relationship between 
the change in lysolipid concentration and lipidation activity.
In DOPC and DOPC/DOPS membranes, a number of compounds 
yielded significant increases in the concentration of oleoyl phos-
phatidylcholine (OPC) without concomitant detection of a lipidated 
product. In these cases, it must be assumed that lipid hydrolysis 
arises via the catalytic route in Fig. 1. Compounds 11a to 11d were 
generally effective at increasing lysolipid formation in most systems, 
yet, of these, only 11b generates a detectable lipidation product. A 
comparison of compounds 11c, 10i, and 17 is revealing because, of 
these, 11c generates lysolipid without lipidation, whereas the other 
two generate lipidation without generating excess lysolipid. All three 
of these compounds have the same aminopropyl group, which 
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Fig. 3. Reaction profiles for compound 9e with DOPC and POPC. In all cases, † identifies the peak corresponding to oleoyl-9e, ‡ identifies the peak corresponding to 
palmitoyl-9e, and impurities are identified by asterisks. 1-PPC and 2-PPC correspond respectively to 1-palmitoyl-sn-glycero-3-phosphocholine and 2-palmitoyl-sn-glycero- 
3-phosphocholine. (A and B) Base peak chromatograms (m/z range, 100 to 650) after 9e addition to DOPC (A) or POPC (B) membranes after 24 and 72 hours. Chromato-
grams after 72 hours have been offset on the y axis by an arbitrary amount. a.u., arbitrary units. (C) Mass spectrum of oleoyl-9e from (A) (theoretical m/z [M + H]+, 
412.3312). (D) Mass spectrum of palmitoyl-9e from (B) (theoretical m/z [M + H]+, 386.3156). (E and F) Tandem mass spectra resulting from the fragmentation of the [M + H]+ 
ions for oleoyl-9e and palmitoyl-9e from (C) and (D), respectively.
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suggests that some of their reactivity is dictated by the partitioning 
behavior of the aromatic group in the membrane interface.
It should be noted that the hydrolysis and acyl transfer (lipidation) 
reactions differ in their ability to generate lysolipid. The hydrol-
ysis reaction is catalytic and therefore has the potential to generate 
a large excess of lysolipid with respect to the quantity of compound 
present. Conversely, if a compound exhibits lipidation activity alone 
(i.e., without concomitant changes in the levels of hydrolysis), then 
the maximum quantity of lysolipid formed will be equivalent to the 
quantity of compound that has participated in the acyl transfer re-
action. A consequence of this 1:1 stoichiometry is that, in many cases, 
even where an acyl transfer reaction has gone to completion and the 
compound has been completely consumed, the quantity of lysolipid 
formed with respect to the total lipid will remain very small and 
may fall below the detection limit for many analytical methods.
Correlation between reactivity and predicted  
molecular properties
Most compounds for which unambiguous lipidation is reported are 
amines for which the predicted ammonium ion pKa is more than 
1 pH unit greater than pH 7.4 (table S1), the pH at which the experi-
ments were conducted. The exceptions are 9a (predicted to be 8.16), 
10h (6.93), and 14 (3.79). These pH differentials, even allowing for 
differences in the pKa between the membrane-associated form and 
the form in solution, imply that, for most compounds, the lipida-
tion reaction does not require the amino form of the compound to 
be predominant at the pH of the experiment. The compounds that 
undergo unambiguousx lipidation have predicted logP values in the 
range of −1.19 (9e) to 2.26 (21), with the majority being close to 1 
(table S1). Their logD values cover the range of −1.63 to 0.72, with most 
being <0. Therefore, with the possible exception of 21, none would 
normally be considered to be sufficiently hydrophobic that they would 
be expected to partition into lipid membranes with high affinity.
Reaction selectivity
In DOPC/DOPS membranes, lipidation is found with the same 
compounds that are reactive with DOPC but with subtle changes in 
reactivity. Notably, the reduction in lysolipid levels after 24 hours 
for many of the most active compounds in DOPC is generally not 
seen in DOPC/DOPS. This observation is significant because it 
demonstrates selectivity at the level of membrane composition. In 
addition, in all samples where lyso-phosphatidylcholine (lyso-PC)
was formed, lyso-phosphatidylserine (lyso-PS) was also generated, 
which would be significant if replicated in vivo given the high bio-
logical activity of lysolipids (17) and the particular role of lyso-PS in 
the immune response (19).
Compounds 10a and 10d to 10g form a homologous series from 
a primary amino compound (10a) through a series of secondary 
amines of increasing steric bulk. Of this series, 10a produces signifi-
cant evidence of lipidation, 10d is potentially lipidated, but the evi-
dence for lipidated product formation is tentative, and none of the 
others yield any evidence of lipidation or increased formation of 
oleoyl PC. When comparing similarly homologous pairings of a 
primary amine with its N-ethyl secondary amine equivalent, such as 
compounds 10h (strong lipidation) versus 10j (potentially weak lip-
idation) and 11b (lipidation) versus 11d (no lipidation), it becomes 
apparent that steric bulk close to the nucleophilic center significantly 
reduces the aminolysis activity.
To probe the selectivity for acyl chain transfer, a selection of 
compounds, composed mostly of examples for which there was clear 
lipidation in DOPC, was examined further in membranes com-
posed of POPC or 1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine 
(OPPC). The lipidation data for these are in Table 2 (lysolipid for-
mation) and tables S3 to S7 (spectra of lipidated derivatives). In 
general, the data for POPC and OPPC are as anticipated on the 
basis of the prior experiments with DOPC, with typically <5–parts 
per million error between the observed and predicted mass/charge 
ratio (m/z) for [M + H]+ for each palmitoylated and oleoylated com-
pound. Many of the lipidated amines yielded fragmentation patterns in 
accordance with those expected for amides, with cleavage of the N─C(alkyl) 
bond particularly prevalent for species able to form benzylic cations 
(20). For example, both oleoyl (Fig. 3C) and palmitoyl (Fig. 3D) deriv-
atives of 9e yielded the same fragment with m/z 131.1 ([indazole─CH2]+; 
Fig. 3, E and F) when the parent [M + H]+ ions (m/z 412.3 and 386.3, 
respectively) were fragmented by collision- induced decay.
Across the sample set as a whole, no compounds exhibited absolute 
selectivity for the formation of a particular acylated product, although 
compound 8 (table S3) was unique in having a very high selectivity 
for formation of the oleoyl derivative in both OPPC and POPC mem-
branes. Some of the compounds in the indazole series (notably 9b-d) 
formed the oleoyl derivative ahead of the palmitoyl derivative.
DISCUSSION
Agents that are capable of binding to membranes fall into one of 
two categories: Either they have no effect on lipid stability, or they are 
0
25
0
50
0
4.3 4.7 5.1
0
13
00
26
00
4.3 4.7 5.1
0
45
0
90
0
4.3 4.7 5.1
0
90
00
18
,0
00
4.3 4.7 5.1
*
A
B
24 hours 72 hours
24 hours 72 hours
Co
nt
ro
l
Co
nt
ro
l
Co
nt
ro
l
Co
nt
ro
l
r.t./min
10
−3
 ×
 in
te
ns
ity
/a
.u
.
r.t./min
r.t./min r.t./min
10
−3
 ×
 in
te
ns
ity
/a
.u
.
Fig. 4. Lysolipid formation during incubation of compound 9e with DOPC and 
POPC. Expanded views of the base peak chromatograms (m/z range, 100 to 650) 
from LC-MS analysis of mixtures of 9e with DOPC (A) or POPC (B) liposomes. Data 
from the corresponding blanks (DOPC or POPC without the addition of 9e) are shown 
as dashed lines. r.t., retention time. The peak marked with an asterisk is an impurity.
 o
n
 M
ay 27, 2020
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Britt et al., Sci. Adv. 2020; 6 : eaaz8598     22 April 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
5 of 7
able to moderate lysis by acting as fatty acyl acceptors or catalyzing 
hydrolysis. It has previously been demonstrated that lipidation of 
the -blocker propranolol yields a product that disrupts the 
membrane integrity of liposomes and has surfactant properties, 
with a critical micelle concentration of approximately 10−5 M (13). 
Compounds that induce lysolipid formation have also been linked 
with idiosyncratic toxic effects in vivo such as drug-induced phos-
pholipidosis (13, 14). It is likely, therefore, that many agents that 
affect lipid stability have similar activity. High membrane affinity is 
not a prerequisite for high lytic activity. Agents that catalyze hydrol-
ysis require at least one center that is acidic or basic and is presum-
ably located in the interfacial region in the membrane-associated 
form. Acyl group acceptors require the presence of at least one 
nucleophilic center that is suitably disposed for reaction with a lipid 
carbonyl group. Of the agents that are able to serve as acyl group 
acceptors, many show a modest selectivity for the acyl derivative 
formed. This acyl selectivity, alongside the change in lysolipid 
concentration, can be used to classify the compounds.
Classification of compounds that undergo lipidation
Compounds can be classified in one of three general ways according 
to their behavior in DOPC, POPC, and OPPC.
Type I compounds, typified by 8 (table S3), 10h-j (tables S6 to S7), 
11a-d, 14, 16, 17, and 20, produce an increase in the concentrations 
of OPC and palmitoyl phosphatidylcholine (PPC) after 24 hours in 
comparison to controls, either through a higher aminolysis reactivity 
with lipids than lysolipids or because they increase the rate of lipid 
hydrolysis. For most cases in POPC membranes, the increase in OPC 
concentration is greater than that of PPC, whereas for OPPC, the 
increases in OPC and PPC concentration are similar. Examination 
of the extracted ion chromatograms for the lipidated species reveals 
that most of these compounds display some selectivity, albeit very 
small, for the acyl group transferred to the compound. The under-
lying mechanisms for this selectivity are likely to be complex. Com-
pound 10h, for example, preferentially forms the oleoyl-modified 
species in POPC membranes and the palmitoyl-modified species 
in OPPC membranes (table S6), while producing the changes in 
lysolipid described above that favor OPC formation in POPC and 
equal formation of OPC and PPC in OPPC (Table 2). In contrast, 
compound 10i is notable in favoring the formation of the palmitoyl- 
modified product in both POPC and OPPC membranes (table S7), 
while producing low levels of OPC formation alongside significant 
PPC formation in the case of OPPC membranes. These patterns of 
product formation can only be rationalized by considering aminolysis 
reactivity with the lipid and the lysolipids alongside hydrolysis 
activity catalyzed by either the unmodified or the lipidated compound 
(or both). Consistent with this complex lytic mechanism, an increased 
abundance of the ion corresponding to the 3-phosphoglycerol 
Table 2. Lysolipid formation in membranes composed of POPC or OPPC in the presence of low–molecular weight organic compounds. Errors are ±  
(n = 3). All values given those after subtraction of the OPC concentration in a control without compound incubated in the same conditions. For POPC, the 
concentrations in controls (without compound) after 24 hours were as follows: [OPC], 0.013 ± 0.004 mM; [PPC], 0.010 ± 0.003 mM. For OPPC, the concentrations 
in controls after 24 hours were as follows: [OPC], 0.006 ± 0.001 mM; [PPC], 0.006 ± 0.002 mM. 
Compound
POPC OPPC
[OPC] change after  
24 hours/mM
[PPC] change after  
24 hours/mM
[OPC] change after  
24 hours/mM
[PPC] change after  
24 hours/mM
3 −0.002 ± 0.005 −0.003 ± 0.004 −0.002 ± 0.002 −0.001 ± 0.003
8 0.013 ± 0.007 0.013 ± 0.007 0.011 ± 0.004 0.012 ± 0.005
9a −0.012 ± 0.004 −0.010 ± 0.004 −0.003 ± 0.001 −0.002 ± 0.002
9b −0.012 ± 0.004 −0.010 ± 0.004 0.000 ± 0.002 0.000 ± 0.002
9c −0.013 ± 0.004 −0.010 ± 0.004 −0.001 ± 0.002 −0.001 ± 0.002
9d −0.006 ± 0.005 −0.006 ± 0.005 −0.001 ± 0.002 −0.001 ± 0.002
9e −0.009 ± 0.005 −0.009 ± 0.004 −0.005 ± 0.001 −0.004 ± 0.002
10a −0.006 ± 0.005 −0.007 ± 0.004 −0.004 ± 0.001 −0.002 ± 0.002
10h 0.047 ± 0.014 0.034 ± 0.010 0.007 ± 0.003 0.007 ± 0.004
10i 0.017 ± 0.008 0.011 ± 0.006 0.004 ± 0.003 0.028 ± 0.008
10j 0.025 ± 0.010 0.015 ± 0.007 0.010 ± 0.004 0.008 ± 0.004
11a 0.039 ± 0.012 0.026 ± 0.009 0.001 ± 0.002 0.002 ± 0.003
11b 0.027 ± 0.010 0.015 ± 0.007 0.065 ± 0.014 0.060 ± 0.014
11c 0.033 ± 0.011 0.016 ± 0.007 0.001 ± 0.002 0.000 ± 0.003
11d 0.027 ± 0.010 0.016 ± 0.007 0.001 ± 0.002 0.001 ± 0.003
13 −0.003 ± 0.005 −0.002 ± 0.004 0.000 ± 0.002 0.001 ± 0.003
14 0.007 ± 0.006 0.005 ± 0.005 0.021 ± 0.006 0.023 ± 0.007
16 0.014 ± 0.008 0.011 ± 0.006 0.004 ± 0.003 0.002 ± 0.003
17 0.008 ± 0.007 0.007 ± 0.006 0.014 ± 0.005 0.014 ± 0.005
19 −0.006 ± 0.004 −0.004 ± 0.004 −0.002 ± 0.002 −0.002 ± 0.003
20 0.010 ± 0.007 0.007 ± 0.006 −0.004 ± 0.002 −0.004 ± 0.002
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derivative glycerophosphocholine (GPC; Fig. 1 and figs. S2 and S3), 
formed by lysis of both acyl chains, was detectable in many experi-
ments with lipidation type 1 compounds. As the chromatography 
was optimized for less polar compounds and GPC was therefore in 
the injection peak, only a semiquantitative assessment, however, is 
merited.
Type II compounds, including 9a-d (table S4), 9e (Fig. 3), 10a 
(table S5), and 19, exhibit a reduction in the concentrations of OPC 
and PPC in comparison to control samples after 24 hours. In prin-
ciple, this reduction can arise either because the compound has a 
higher aminolysis reactivity with the lysolipid than the lipid or be-
cause the compound reduces rate of background hydrolysis. The 
latter mechanism would appear most likely as the levels of GPC 
remain the same or even decrease after 24 hours in the presence of 
these compounds (fig. S2). There is no observed difference in the 
reduction in OPC versus PPC, but there is evidence of some selec-
tivity in the chromatographic profiles for the lipidated species 
(tables S4 and S5). Compound 9a, for example, exhibits an increased 
formation of oleoylated compound in comparison to the palmitoylated 
species in POPC, whereas in OPPC, the palmitoylated species is in 
greater abundance. Given the low formation of GPC, it is likely that 
this small degree of acyl selectivity arises from a preferential reac-
tion at the sn-2 acyl group of the lipid.
Type III compounds, typified by 3 and 13, produce little change 
in the levels of OPC and PPC in comparison to controls, either 
because the level of background reactivity is small or the rate of lyso-
lipid generation by hydrolysis and aminolysis is matched by the rate 
of lysolipid consumption by aminolysis.
CONCLUSIONS
Our data demonstrate that (i) low–molecular weight molecules with 
low predicted logP/logD partake in membrane-lytic reactions. A 
strong membrane interaction is not a requirement for lytic activity; 
(ii) the reactivity exhibits selectivity according to both the chemical 
structure of the molecule interacting with the membrane and the 
chemical composition of the membrane. Therefore, in principle, it 
should be possible to predict or design such activity, although the 
rules for these processes are still not fully understood; and (iii) the 
formation of lysolipids is not a reliable measure of the lytic potential 
of a given compound.
A more thorough understanding of the patterns of reactivity ex-
hibited by membrane-associating molecules decorated with nucleo-
philic centers, such as the aromatic amines, alcohols, and thiols 
used in this study, will require detailed mechanistic studies to delin-
eate the relative importance of membrane interfacial binding depth 
and orientation, interfacial water activity, and structural parameters 
such as the presence of internal basic sites.
MATERIALS AND METHODS
Materials
DOPC, POPC, OPPC, DOPS, 1-OPC, and 1-palmitoyl-sn-glycero-
3- phosphocholine (1-PPC) were purchased as powders from Avanti 
Polar Lipids (via INstruchemie B.V., The Netherlands or Sigma- 
Aldrich, Dorset, UK). Compounds 2 (A00.537.799), 3 (K00.128.576), 
4 (A00.388.211), 5 (K02.783.027), 6 (A00.788.063), 9a (A05.891.682), 
9b (A06.826.360), 9c (A06.788.730), 9d (A02.626.646), 9e 
(A06.826.359), 10h (K00.644.797), 10a (K02.035.210), 10i 
(K00.242.288), 10j (A01.480.727), 11a (A00.739.562), 11b (A00.000.070), 
11c (K01.793.053), 11d (A05.884.302), 12 (A00.704.412), 13 (A00.152.963), 
17 (A00.064.429), 19 (A01.075.774), and 20 (A01.072.662) were pur-
chased from Aurora Fine Chemicals (San Diego, CA 92126, USA) (prod-
uct numbers at time of purchase in parentheses).
Compounds 14 (FCH1116113), 15 (FCH867785), and 16 
(FCH998721) were purchased from FCH, Chernigiv, Ukraine 
(product numbers at time of purchase in parentheses).
Other compounds and solvents were purchased from Sigma- 
Aldrich (Dorset, UK), Fluorochem (Hadfield, UK), Alfa Aesar 
(Heysham, UK), or Fisher Scientific (Loughborough, UK).
Liposome preparation
Liposomes were prepared by drying a solution of the lipid from a 
solution in chloroform to form a thin film around the side of a 
round-bottomed flask. This film was then hydrated with buffer and, 
after thorough vortex mixing, was subjected to five freeze-thaw 
cycles using liquid nitrogen and a warm water bath (40°C). The vesi-
cles were then extruded 10× through laser-etched polycarbonate 
membranes (Whatman; 100-nm pore size) at 50°C using a thermo-
barrel extruder (Northern Lipids, Burnaby, Canada) under a posi-
tive pressure of N2.
Lipidation in liposomes
All liposome experiments were conducted at a lipid concentration 
of 1.27 mM. Compounds tested for membrane-lytic activity were 
used at a concentration of 0.127 mM. Samples at pH 7.4 were buff-
ered using 10 mM sodium bicarbonate and contained NaCl at a 
concentration of 90 mM. Samples were made by adding compound 
solutions to preformed liposome dispersions before incubation in a 
sealed vial in either a temperature controlled thermal block or a 
thermostated shaking incubator. For analysis by LC-MS, a small 
volume (typically <20 l) of the reaction mixture was removed and 
diluted into MeCN/H2O (1:1) in a sample vial to give a drug con-
centration of 1 g/ml. The sample injection volume was 3 l.
Liquid chromatography–mass spectrometry
LC-MS and LC–tandem MS (MS/MS) data were acquired on a 
SYNAPT G2-S (Waters Corporation, UK) instrument, with time-of- 
flight analyzer recording electrospray ionization ions in the range of 
50 to 2000 m/z and a scan time of 1.0 s. For the analysis of mixtures 
of compounds with liposomes, chromatography was conducted 
using a 3-l sample injection on to an Acquity Ultra Performance 
Liquid Chromatography (UPLC) equipped with a BEH Phenyl 
1.7 m; 2.1 mm by 50 mm) column. The flow rate was 0.4 ml/min. 
The solvent gradient (A:B), using H2O (A) and MeCN (B), with 
both solvents containing 0.1% formic acid, was either (gradient 1): 
95:5 over 0.5 min (isocratic), 95:5 to 30:70 over 2.5 min, 30:70 to 
5:95 over 4 min, 5:95 (isocratic) for 1 min, 5:95 to 95:5 over 0.5 min, 
95:5 (isocratic) for 0.5 min; or (gradient 2): 95:5 over 0.5 min (isocratic), 
95:5 to 5:95 over 7 min, 5:95 (isocratic) for 1.3 min, 5:95 to 95:5 over 
0.1 min, 95:5 (isocratic) for 1.1 min.
All solvent transitions used linear gradients. The electrospray 
parameters were as follows: capillary voltage, 1 kV; source tem-
perature, 150°C; sampling cone voltage, 50 V; source offset voltage, 
30 V; desolvation temperature, 350°C; cone gas flow, 60 liters hour−1; 
desolvation gas flow, 600 liters hour−1; and nebulizer gas flow, 6 bar.
Collision-induced dissociation (CID) MS/MS was carried out in 
the trap region of a SYNAPT G2-S (Waters Ltd., UK). Desired 
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precursor ions were isolated in the quadrapole and subsequently 
underwent CID fragmentation ramping from 30 to 50 V.
The data were processed using MassLynx software (version 4.1 
SCN924), MZmine (version 2.38), (21) and the xcms LC-MS and 
gas chromatography–MS data analysis package (version 1.52.0) (22) 
in the R statistical computing environment (version 3.4.1) (23).
Calibration curves
Signal responses were determined by the least-squares fitting of 
Exponentially Modified Gaussian functions (24) to peak profiles 
from the extracted ion chromatograms (m/z for the monoisotopic 
molecular ion, z = 1, ±0.005) of the ions of interest. A standard 
curve for signal response in relation to lysolipid concentration was 
generated by least-squares fitting of a general logistic model (Eq. 1) 
to data obtained using an authentic standard of OPC at known in-
jection concentrations.
  A calc =  A u / 1 +  e −s(c− c 0.5 ) (1)
where Acalc is the calculated value, Au is the maximum area, s is the 
steepness of the curve, c is the natural logarithm of the analyte con-
centration, and c0.5 is the natural logarithm of the concentration at 
half maximum. Fitting data are presented in fig. S1.
Molecular information
Molecular properties were calculated using Advanced Chemistry 
Development (ACD) Labs software accessed through Chemical 
Abstracts Service/SciFinder (18). Values for pKa were calculated at 
25°C and zero ionic strength in aqueous solutions for the most acidic 
or most basic sites in the molecule (with the pKa for the most basic 
site in the protonated form). Values for logP and logD were calcu-
lated at pH 7 and 25°C (in the neutral form for logP and the pre-
dominant predicted ionization state at this pH for logD).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/17/eaaz8598/DC1
View/request a protocol for this paper from Bio-protocol.
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